The financials
Lumexa Imaging Holdings, Inc. by the numbers
Lumexa Imaging Holdings, Inc. (LMRI) reported revenue of $264M in Q2 2026 (quarter ended Jun 30, 2026), up 7.8% from the same quarter a year earlier. That came with net income of $2.7M (1.0% of revenue). Its largest product in Q2 2026 was Health Care Patient Service at $195M, 67% of the disclosed total, well ahead of Management Fee And Other Revenue Related Party at 18%.
| Income statement | Q2 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $264M | $245M | +7.8% |
| Operating income | $23M | $26M | −9.8% |
| Net income | $2.7M | −$7.7M | to a profit |
| Diluted EPS | $0.03 | −$0.11 | to a profit |
| Product | Revenue | Share |
|---|---|---|
| Health Care Patient Service | $195M | 67% |
| Management Fee And Other Revenue Related Party | $52M | 18% |
| Management Fee And Other | $37M | 13% |
| Investment Advisory Management And Administrative Service | $8.7M | 3.0% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q2 2026Total $292.7M (+4.7%)
Segment Latestquarter on quarteryear on year
- Health Care Patient Service$194.9M$194.9MQoQ +3.1%year on year +2.9%+3.1%+2.9%
- Management Fee And Other Revenue Related Party$51.7M$51.7MQoQ +4.4%year on year +6.9%+4.4%+6.9%
- Management Fee And Other$37.4M$37.4MQoQ +5.4%year on year +7.2%+5.4%+7.2%
- Investment Advisory Management And Administrative Service$8.7M$8.7MQoQ +53%year on year +81%+53%+81%
Medical Devices
The closest names by size in the same industry